GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
Sep 03, 2024
Read
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
Sep 03, 2024
Read
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024
Read
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
Feb 29, 2024
Read
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
Jan 18, 2024
Read